ANIXA BIOSCIENCES INC's ticker is ANIX and the CUSIP is 03528H109. A total of 17 filers reported holding ANIXA BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Concorde Asset Management, LLC | 13,000 | $50,000 | 0.03% |
| B. Riley Wealth Management, Inc. | 12,000 | $47,000 | 0.01% |
| Accel Wealth Management | 1,250 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,979 | $77,000 | 0.00% |
| Spire Wealth Management | 17,500 | $68,000 | 0.00% |
| UBS Group AG | 687,302 | $2,667,000 | 0.00% |
| SEGALL BRYANT & HAMILL, LLC | 17,400 | $68,000 | 0.00% |
| Renaissance Technologies | 124,499 | $483,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 61,638 | $239,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 21 | $0 | 0.00% |